News Center
Welcome to the Tibotec Therapeutics News Center. Here you can find recent news releases issued by Tibotec Therapeutics.
Press Releases
We are committed to ensuring that our stakeholders have access to the latest information about Tibotec Therapeutics to learn about developments in our business. We regularly update these pages so that you can stay in touch with our news and activities.
U.S. Food and Drug Administration Approves Labeling Update for PREZISTA® To Include 96-Week Data in HIV-1 Infected Adult Patients
U.S. Food and Drug Administration (FDA) Grants Traditional Approval for INTELENCE® (etravirine)
PREZISTA ®Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy